gallocatechol has been researched along with Diabetes Mellitus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, W; Wang, C; Wang, M; Zhang, X; Zhou, C; Zhou, F; Zhou, W | 1 |
1 other study(ies) available for gallocatechol and Diabetes Mellitus
| Article | Year |
|---|---|
Design and synthesis of epigallocatechin (EGC) analogs selective to inhibit α-amylase over α-glucosidases via the incorporation of caffeine acid and its derivatives.
Topics: alpha-Amylases; alpha-Glucosidases; Caffeic Acids; Catechin; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Design; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2022 |